Differential intracellular transport and binding of verotoxin 1 and verotoxin 2 to globotriaosylceramide-containing lipid assemblies

Journal of Cellular Physiology

Volumn 216, Issue 3, 2008, Pages 750-763

  Tam, Patty ^a,b   Mahfoud, Radhia ^b   Nutikka, Anita ^b   Khine, Aye Aye ^b   Binnington, Beth ^b   Paroutis, Paul ^b   Lingwood, Clifford ^a,b,c  

^a UNIVERSITY OF TORONTO   (Canada)

^b HOSPITAL FOR SICK CHILDREN RESEARCH INSTITUTE   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL; GLOBOTRIAOSYLCERAMIDE; IODINE 125; SPHINGOMYELIN; SUCROSE; TRANSFERRIN; VEROTOXIN 1; VEROTOXIN 2;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL NUCLEUS MEMBRANE; CELL SURFACE; CELL VACUOLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOPATHOLOGY; ENDOPLASMIC RETICULUM; ESCHERICHIA COLI; GOLGI COMPLEX; IN VITRO STUDY; INTRACELLULAR TRANSPORT; LIPID RAFT; MEMBRANE BINDING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN TRANSPORT;

ANIMALS; BIOLOGICAL TRANSPORT; CELL LINE; CELL MEMBRANE; GOLGI APPARATUS; HUMANS; LIPIDS; PROTEIN BINDING; SHIGA TOXIN 1; SHIGA TOXIN 2; TRIHEXOSYLCERAMIDES; VACUOLES;

ANIMALIA;

EID: 48749104439     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcp.21456     Document Type: Article

References (98)

1. Arab S, Lingwood CA. 1996. Influence of phospholipid chain length on verotoxin/globotriaosyl ceramide binding in model membranes: Comparison of a surface bilayer film and liposomes. Glycoconjugate J 13:159-166.
2. Arab S, Lingwood C. 1998. Intracellular targeting of the endoplasmic reticulum/nuclear envelope by retrograde transport may determine cell hypersensitivity to Verotoxin: Sodium butyrate or selection of drug resistance may induce nuclear toxin targeting via globotriaosyl ceramide fatty acid isoform traffic. J Cell Physiol 177:646-660.
3. Baumgart T, Hammond AT, Sengupta P, Hess ST, Holowka DA, Baird BA, Webb WW. 2007. Large-scale fluid/fluid phase separation of proteins and lipids in giant plasma membrane vesicles. Proc Natl Acad Sci USA 104:3165-3170.
4. Binnington B, Lingwood D, Nutikka A, Lingwood C. 2002. Effect of globotriaosyl ceramide fatty acid hydroxylation on the binding by verotoxin 1 and verotoxin 2. Neurochem Res 27:807-813.
5. Boerlin P, McEwen SA, Boerlin-Petzold F, Wilson JB, Johnson RP, Gyles CL. 1999. Associations between virulence factors of Shiga toxin-producing Escherichia coli and disease in humans. J Clin Microbiol 37:497-503.
6. Boulanger J, Petric M, Lingwood CA, Law H, Roscoe M, Karmali M. 1990. Neutralization receptor-based immunoassay (NeutrELISA) for detection of neutralizing antibodies to Escherichia coli verocytotoxin I. J Clin Micro 28:2830-2833.
7. Boulanger J, Huesca M, Arab S, Lingwood CA. 1994. Universal method for the facile production of glycolipid/lipid matrices for the affinity purification of binding ligands. Anal Biochem 217:1-6.
8. Boyd B, Zhiuyan Z, Magnusson G, Lingwood CA. 1994. Lipid modulation of glycolipid receptor function: Presentation of galactose α1-4 galactose disaccharide for Verotoxin binding in natural and synthetic glycolipids. Eur J Biochem 223:873-878.
9. Chark D, Nutikka A, Trusevych N, Kuzmina J, Lingwood C. 2004. Differential carbohydrate epitope recognition of globotriaosyl ceramide by verotoxins and monoclonal antibody: Role in human renal glomerular binding. Eur J Biochem 271:1-13.
10. Cimolai N, Carter JE, Morrison BJ, Anderson JD. 1990. Risk factors for the progression of Escherichia coli O157:H7 enteritis to hemolytic uremic syndrome. J Pediatr 116:589-592.
11. Connell SD, Smith DA. 2006. The atomic force microscope as a tool for studying phase separation in lipid membranes. Mol Membr Biol 23:17-28.
12. Dalskov SM, Immerdal L, Niels-Christiansen LL, Hansen GH, Schousboe A, Danielsen EM. 2005. Lipid raft localization of GABA A receptor and Na+, K+-ATPase in discrete microdomain clusters in rat cerebellar granule cells. Neurochem Int 46:489-499.
13. Duncan M, Shin J, Abraham S. 2002. Microbial entry through caveolae: Variations on a theme. Cell Microbiol 4:783-791.
14. Falguieres T, Mallard F, Baron C, Hanau D, Lingwood C, Goud B, Salamero J, Johannes L. 2001. Targeting of Shiga toxin b-subunit to retrograde transport route in association with detergent-resistant membranes. Mol Biol Cell 12:2453-2468.
15. Fischer H, Ellstrom P, Ekstrom K, Gustafsson L, Gustafsson M, Svanborg C. 2007. Ceramide as a TLR4 agonist; a putative signalling intermediate between sphingolipid receptors for microbial ligands and TLR4. Cell Microbiol 9:1239-1251.
16. Fraser ME, Fujinaga M, Cherney MM, Melton-Celsa AR, Twiddy EM, O'Brien AD, James MN. 2004. Structure of Shiga toxin type 2 (Stx2) from Escherichia coli O15. J Biol Chem 279:27511-27517.
17. Fujii J, Kita T, Yoshida SI, Takeda T, Kobayashi H, Tanaka N, Ohsato K, Mizuguchi Y. 1994. Direct evidence of neuron impairment by oral infection with verotoxin-producing Escherichia coli O157:H- in mitomycin-treated mice. Infect Immun 62:3447-3453.
18. Fujii J, Kinoshita Y, Yutsudo T, Taniguchi H, Obrig T, Yoshida SI. 2001. Toxicity of Shiga toxin 1 in the central nervous system of rabbits. Infect Immun 69:6545-6548.
19. Gallegos AM, McIntosh AL, Atshaves BP, Schroeder F. 2004. Structure and cholesterol domain dynamics of an enriched caveolae/raft isolate. Biochem J 382:451-461.
20. Gaus K, Gratton E, Kable EP, Jones AS, Gelissen I, Kritharides L, Jessup W. 2003. Visualizing lipid structure and raft domains in living cells with two-photon microscopy. Proc Natl Acad Sci USA 100:15554-15559.
21. Griffin PM. 1995. Escherichia coli O157:H7 and other enterohemorrhagic Escherichia coli In: Blaser MJ, Smith PD, Ravdin JI, Greenberg HB, Guerrant RL, editors. Infections of the gastrointestinal tract. New York: Raven Press, Ltd. pp 739-761, Ch. 716.
22. Hakomori S-I. 2000. Cell adhesion/recognition and signal transduction through glycosphingolipid microdomain. Glycoconjugate J 17:143-151.
23. Hakomori SI. 2002. The glycosynapse. Proc Natl Acad Sci USA 99:225-232.
24. Hakomori S, Handa K, Iwabuchi K, Yamamura S, Prinetti A. 1999. New insights in glycosphingolipid function: "glycosignaling domain," a cell surface assembly of glycosphingolipids with signal transducer molecules, involved in cell adhesion coupled with signaling. Biochemistry 38:3369-3378.
25. Head S, Karmali M, Lingwood CA. 1991. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits: Evidence for B subunit modulation of A subunit function. J Biol Chem 266:3617-3621.
26. Hemler ME. 2003. Tetraspanin proteins mediate cellular penetration, invasion, and fusion events and define a novel type of membrane microdomain. Annu Rev Cell Dev Biol 19:397-422.
27. Hoey DEE, Currie C, Lingwood CA, Gally DL, Smith DGE. 2003. Binding of verotoxin 1 to primary intestinal epithelial cells expressing Gb3 results in trafficking of toxin to lysosomal compartments. Cell Microbiol 5:85-97.
28. Holopainen JM, Metso AJ, Mattila JP, Jutila A, Kinnunen PK. 2004. Evidence for the lack of a specific interaction between cholesterol and sphingomyelin. Biophys J 86:1510-1520.
29. Jackson M, Simpson J, Girod A, Pepperkok R, Roberts L, Lord J. 1999. The KDEL retrieval system is exploited by Pseudomonas exotoxin A, but not by Shiga-like toxin-1, during retrograde transport from the Golgi complex to the endoplasmic reticulum. J Cell Sci 112:467-475.
30. Jacobson K, Mouritsen OG, Anderson RG. 2007. Lipid rafts: At a crossroad between cell biology and physics. Nat Cell Biol 9:7-14.
31. Karmali MA. 2004. Infection by Shiga toxin-producing Escherichia coli: An overview. Mol Biotechnol 26:117-122.
32. Katagiri Y, Mori T, Nakajima H, Katagiri C, Taguchi T, Takeda T, Kiyokawa N, Fujimoto J. 1999. Activation of Src family kinase induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J Biol Chem 274:35278-35282.
33. Kawakami Y, Kawakami K, Steelant WF, Ono M, Baek RC, Handa K, Withers DA, Hakomori S. 2002. Tetraspanin CD9 is a "proteolipid," and its interaction with alpha 3 integrin in microdomain is promoted by GM3 ganglioside, leading to inhibition of laminin-5-dependent cell motility. J Biol Chem 277:34349-34358.
34. Khine AA, Lingwood CA. 1994. Capping and receptor mediated endocytosis of cell bound verotoxin (Shiga-like toxin) I; Chemical identification of an amino acid in the B subunit necessary for efficient receptor glycolipid binding and cellular internalization. J Cell Physiol 161:319-332.
35. Khine AA, Tam P, Nutikka A, Lingwood CA. 2004. Brefeldin A and filipin distinguish two Globotriaosyl ceramide/ Verotoxin-1 intracellular trafficking pathways involved in Vero cell cytotoxicity. Glycobiology 14:701-712.
36. Kiarash A, Boyd B, Lingwood CA, 1994. Glycosphingolipid receptor function is modified by fatty acid content Verotoxin 1 and Verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J Biol Chem 269:11138-11146.
37. Kiyokawa E, Baba T, Otsuka N, Makino A, Ohno S, Kobayashi T. 2005. Spatial and functional heterogeneity of sphingolipid-rich membrane domains. J Biol Chem 280:24072-24084.
38. Kleanthous H, Smith HR, Scotland SM, Gross RJ, Rowe B, Taylor CM, Milford DV. 1990. Haemolytic uraemic syndrome in the British Isles, 1985-1988: Association with Verocytotoxin producing Escherichia coli. Part 2. Microbiological aspects. Arch Dis Child 65:722-727.
39. Lauvrak SU, Walchli S, Iversen TG, Slagsvold HH, Torgersen ML, Spilsberg B, Sandvig K. 2005. Shiga toxin regulates its entry in a Syk-dependent manner. Mol Biol Cell 17:1096-1109.
40. Le P, Nabi I. 2003. Distinct caveolae-mediated endocytic pathways target the Golgi apparatus and the endoplasmic reticulum. J Cell Sci 116:1059-1071.
41. Lencer WI, Hirst TR, Holmes RK. 1999. Membrane traffic and the cellular uptake of cholera toxin (review). Biochim Biophys Acta 1450:177-190.
42. Lenne PF, Wawrezinieck L, Conchonaud F, Wurtz O, Boned A, Guo XJ, Rigneault H, He HT, Marguet D. 2006. Dynamic molecular confinement in the plasma membrane by microdomains and the cytoskeleton meshwork. EMBO J 25:3245-3256.
43. 3. Biochemistry 37:1777-1788.
44. Lingwood CA, Mylvaganam M. 2003. Lipid modulation of glycosphingolipid (GSL) receptors: Soluble glycolipid mimics provide new probes of glycolipid receptor function. In: Lee YCLRT, editor. Methods in enzymology. San Diego: Academic Press. pp 264-284.
45. Lingwood D, Simons K. 2007. Detergent resistance as a tool in membrane research. Nat Protocols 2:2159-2165.
46. Lingwood C, Sadacharan S, Abul-Milh M, Mylvaganum M, Peter M. 2006. Soluble adamantyl glycosphingolipid analogs as probes of glycosphingolipid function. Methods Mol Biol 347:305-320.
47. Lippincott-Schwartz J, Yuan L, Tipper C, Amherdt M, Orci L, Klausner RD. 1991. Brefeldin A's effects on endosomes, lysosomes, and the TGN suggest a general mechanism for regulating organelle structure and membrane traffic. Cell 67:601-616.
48. London E, Brown DA. 2000. Insolubility of lipids in triton X-100: Physical origin and relationship to sphingolipid/cholesterol membrane domains (rafts). Biochim Biophys Acta 1508:182-195.
49. Louise C, Obrig T. 1995. Specific interaction of Escherichia coli 0157:H7-derived Shiga-like toxin II with human renal endothelial cells. J Infect Dis 172:1397-1401.
50. Lund N, Branch D, Mylvaganam M, Chark D, Ma X, Sakac D, Binnington B, Fantini J, Puri A, Blumenthal R, Lingwood C. 2006. A novel soluble mimic of the glycolipid globotriaosylceramide inhibits HIV infection. AIDS 20:1-11.
51. 3 interaction. J Lipid Res 43:1670-1679.
52. Mallard F, Tang BL, Galli T, Tenza D, Saint-Pol A, Yue X, Anthony C, Hong W, Goud B. Johannes L. 2002. Early/recycling endosomes-to-TGN transport involves two SNARE complexes and a Rab6 isoform. J Cell Biol 156:653-664.
53. Mamelak D, Mylvaganam M, Tanahashi E, Ito H, Ishida H, Kiso M, Lingwood C. 2001. The aglycone of sulfogalactolipids can alter the sulfate ester substitution position required for hsc70 recognition. Carbohydr Res 335:91-100.
54. Marwali MR, Rey-Ladino J, Dreolini L, Shaw D, Takei F. 2003. Membrane cholesterol regulates LFA-1 function and lipid raft heterogeneity. Blood 102:215-222.
55. Miceli S, Jure MA, de Saab OA, de Castillo MC, Rojas S, de Holgado AP, de Nader OM. 1999. A clinical and bacteriological study of children suffering from haemolytic uraemic syndrome in Tucuman. Argentina Jpn J Infect Dis 52:33-37.
56. Montesano R, Roth J, Robert A, Orci L. 1982. Non-coated membrane invaginations are involved in binding and internalization of cholera and tetanus toxins. Nature 296:651-653.
57. Mori T, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T, Sekino T, Sato N, Ohmi K, Nakajima H, Takeda T, Fukimoto J. 2000. Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating Lyn kinase activity in human B cells. Exp Hematol 28:1260-1268.
58. Mylvaganam M, Lingwood C. 1999. Adamantyl globotriaosyl ceramide - A monovalent soluble glycolipid mimic which inhibits verotoxin binding to its glycolipid receptor. Biochem Biophys Res Commun 257:391-394.
59. Mylvaganam M, Lingwood CA. 2003. A preamble to aglycone reconstruction for membrane-presented glycolipids. In: Wong C-H, editor. Carbohydrate-based drug discovery. Weinheim, Germany: Wiley-VCH Press. pp 761-780.
60. 3Cer binding sites. Biochem J 368:769-776.
61. Nakajima H, Kiyokawa N, Katagiri YU, Taguchi T, Suzuki T, Sekino T, Mimori K, Ebata T, Saito M, Nakao H, Takeda T, Fujimoto J. 2001. Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J Biol Chem 276:42915-42922.
62. Nichols B, Kenworthy A, Polishchuk R, Lodge R, Roberts T, Hirschberg K, Phair RJL-S. 2001. Rapid cycling of lipid raft markers between the cell surface and Golgi complex. J Cell Biol 153:529-541.
63. Nutikka A, Lingwood C. 2004. Generation of receptor active, globotriaosyl ceramide/cholesterol lipid 'rafts' in vitro: A new assay to define factors affecting glycosphingolipid receptor activity. Glycoconjugate J 20:22-38.
64. Nyholm PG. Magnusson G, Zheng Z, Norel R, Binnington-Boyd B, Lingwood CA. 1996. Two distinct binding sites for globotriaosyl ceramide on verotoxins: Molecular modelling and confirmation by analogue studies and a new glycolipid receptor for all verotoxins. Chem Biol 3:263-275.
65. Obrig T, Louise C, Lingwood C, Boyd B, Barley-Maloney L, Daniel T. 1993. Endothelial heterogeneity in Shiga toxin receptors and responses. J Biol Chem 268:15484-15488.
66. Okuda T, Toduda N, Numata S, Ito M, Ohta M, Kawamura K, Weils J, Fujii Y, Urano T, Tajima O, Furukawa K, Furukawa K. 2004. Implication of Gb3 expression in in vivo in hemolytic uremic syndrome. Glycobiology 14:1160.
67. Okuda T, Tokuda N, Numata S, Ito M, Ohta M, Kawamura K, Wiels J, Urano T, Tajima O, Furukawa K. 2006. Targeted disruption of Gb3/CD77 synthase gene resulted in the complete deletion of globo-series glycosphingolipids and loss of sensitivity to verotoxins. J Biol Chem 281:10230-10235.
68. Ostroff SM, Tarr PI, Neill MA, Lewis JH, Hargrett-Bean N, Kobayashi JM. 1989. Toxin genotypes and plasmid profiles as determinants of systemic sequelae in Escherichia coli 0157:H7 infections. J Infect Dis 160:994-998.
69. Pang H, Le PU, Nabi IR. 2004. Ganglioside GMI levels are a determinant of the extent of caveolae/raft-dependent endocytosis of cholera toxin to the Golgi apparatus. J Cell Sci 117:1421-1430.
70. 125I]-VT 1. Biochim Biophys Acta 1501:116-124.
71. Petric M, Karmali MA, Richardson S, Cheung R. 1987. Purification and biological properties of Escherichia coli verocytotoxin. FEMS Microbiol Lett 41:63-68.
72. Pitman MC, Suits F, Mackerell AD, Jr., Feller SE. 2004. Molecular-level organization of saturated and polyunsaturated fatty acids in a phosphatidylcholine bilayer containing cholesterol. Biochemistry 43:15318-15328.
73. Pudymaitis A, Armstrong G, Lingwood CA. 1991. Verotoxin resistant clones are deficient in the glycolipid globotriosyl ceramide: Differential basis of mutant phenotype. Arch Biochem Biophys 286:448-452.
74. Richardson SE, Karmali MA, Becker LE, Smith CR. 1988. The histopathology of the hemolytic uremic syndrome associated with verocy to toxin-producing Escherichia coli infections. Human Pathol 19:1102-1108.
75. Romer W, Berland L, Chambon V, Gaus K, Windschiegl B, Tenza D, Aly MR, Fraisier V, Florent JC, Perrais D, Lamaze C, Raposo G, Steinern C, Sens P, Bassereau P, Johannes L. 2007. Shiga toxin induces tubular membrane invaginations for its uptake into cells. Nature 450:670-675.
76. Rutjes N, Binnington B, Smith C, Maloney M, Lingwood C. 2002. Differential tissue targeting and pathogenesis of Verotoxins 1 and 2 in the mouse animal model. Kidney Int 62:832-845.
77. Saint-Pol A, Yelamos B, Amessou M, Mills IG, Dugast M, Tenza D, Schu P, Antony C, McMahon HT, Lamaze C, Johannes L. 2004. Clathrin adaptor epsinR is required for retrograde sorting on early endosomal membranes. Dev Cell 6:525-538.
78. Sandvig K, Olnes S, Brown J, Peterson O, van Deurs B. 1989. Endocytosis from coated pits of Shiga toxin: A glycolipid-binding protein from Shigella dysenteriae I. J Cell Biol 108:1331-1343.
79. Schapiro F, Lingwood CA, Furuya W, Grinstein S. 1998. pH-independent targeting of glycolipids to the Golgi complex. Am J Physiol 274:319-332.
80. Schuck S, Honsho M, Ekroos K, Shevchenko A, Simons K. 2003. Resistance of cell membranes to different detergents. Proc Natl Acad Sci USA 100:5795-5800.
81. Sekino T, Kiyokawa N, Taguchi T, Takenouchi H, Matsui J, Tang WR, Suzuki T, Nakajima H, Saito M, Ohmi K, Katagiri YU, Okita H, Nakao H, Takeda T, Fujimoto J. 2004. Characterization of a Shiga-toxin 1-resistant stock of vero cells. Microbiol Immunol 48:377-387.
82. Shogomori H, Futerman A. 2001. Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J Biol Chem 276:9182-9188.
83. Simons K, Ehehalt R. 2002. Cholesterol, lipid rafts, and disease. J Clin Invest 110:597-603.
84. Singh RD, Puri V, Valiyaveettil JT, Marks DL, Bittman R, Pagano RE. 2003. Selective caveolin-1-dependent endocytosis of glycosphingolipids. Mol Biol Cell 14:3254-3265.
85. Smith DC, Sillence DJ, Falguieres T, Jarvis RM, Johannes L, Lord JM, Platt FM, Roberts LM. 2006. The association of Shiga-like toxin with detergent-resistant membranes is modulated by glucosylceramide and is an essential requirement in the endoplasmic reticulum for a cytotoxic effect. Mol Biol Cell 17:1375-1387.
86. Soltyk AM, MacKenzie CR, Wolski VM, Hirama T, Kitov PI, Bundle DR, Brunton JL. 2002. A mutational analysis of the globotriaosylceramide binding sites of verotoxin VT1. J Biol Chem 277:5351-5359.
87. St. Hilaire PM, Boyd MK, Toone EJ. 1994. Interaction of the Shiga-like toxin type 1 B-subunit with its carbohydrate receptor. Biochemistry 33:14452-14463.
88. Takenouchi H, Kiyokawa N, Taguchi T, Matsui J, Katagiri YU, Okita H, Okuda K, Fujimoto J. 2004. Shiga toxin binding to globotriaosyl ceramide induces intracellular signals that mediate cytoskeleton remodeling in human renal carcinoma-derived cells. J Cell Sci 117:3911-3922.
89. Tam P, Lingwood C. 2007. Membrane-cytosolic translocation of Verotoxin A1-subunit in target cells. Microbiology 153:2700-2710.
90. Tesh V, Burris J, Owens J, Gordon V, Wadolkowski E, O'Brien A, Samuel J. 1993. Comparison of the relative toxicities of Shiga-like toxins type I and type II for mice. Infect Immun 61:3392-3402.
91. Tetaud C, Falguieres T, Carlier K, Lecluse Y, Garibal J, Coulaud D, Busson P, Steffensen R, Clausen H, Johannes L, Wiels J. 2003. Two distinct Gb3/CD77 signaling pathways leading to apoptosis are triggered byanti-Gb3/CD77mAb and verotoxin-1. J Biol Chem 278:45200-45208.
92. Thompson G, Shimizu H, Homans S, Donohue-Rolfe A. 2000. Localization of the binding site for the oligosaccharide moiety of Gb3 on verotoxin 1 using NMR residual dipolar coupling measurements. Biochemistry 39:13153-13156.
93. van der Goot FG, Harder T. 2001. Raft membrane domains: From a liquid-ordered membrane phase to a site of pathogen attack. Semin Immunol 13:89-97.
94. Veiga MP, Arrondo JL, Goni FM, Alonso A, Marsh D. 2001. Interaction of cholesterol with sphingomyelin in mixed membranes containing phosphatidylcholine, studied by spin-label ESR and IR spectroscopies. A possible stabilization of gel-phase sphingolipid domains by cholesterol. Biochemistry 40:2614-2622.
95. Wassail SR, Brzustowicz MR, Shaikh SR, Cherezov V, Caffrey M, Stillwell W. 2004. Order from disorder, corralling cholesterol with chaotic lipids. The role of polyunsaturated lipids in membrane raft formation. Chem Phys Lipids 132:79-68.
96. Whetstone D, Lingwood C. 2003. 3′Sulfogalactolipid binding specifically inhibits Hsp70 ATPase activity in vitro. Biochemistry 42:1611-1617.
97. Wolf AA, Jobling MG, Wimer-Mackin S, FErguson-Maltzman M, Madara JL, Holmes RK, Lencer WI. 1998. Ganglioside structure dictates signal transduction by cholera toxin and association with caveolae-like membrane domains in polarized epithelia. J Cell Biol 141:917-927.
98. Xu X, Bittman R, Duportail G, Heissler D, Vilcheze C, London E. 2001. Effect of the structure of natural sterols and sphingolipids on the formation of ordered sphingolipid/sterol domains (rafts). Comparison of cholesterol to plant, fungal, and disease-associated sterols and comparison of sphingomyelin, cerebrosides, and ceramide. J Biol Chem 276:33540-33546.